184 related articles for article (PubMed ID: 36380520)
1. Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
Akahoshi T; Kaku N; Shono Y; Yamamoto Y; Takahashi K; Iyonaga T; Momii K; Nishihara M; Maki J; Tokuda K; Yamaura K
Clin Appl Thromb Hemost; 2022; 28():10760296221135790. PubMed ID: 36380520
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure.
Kuroda H; Masuda Y
Clin Appl Thromb Hemost; 2020; 26():1076029620981630. PubMed ID: 33332196
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.
Iba T; Saitoh D; Gando S; Thachil J
Thromb Res; 2015 May; 135(5):897-901. PubMed ID: 25784136
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.
Iba T; Gando S; Saitoh D; Wada H; Di Nisio M; Thachil J
Thromb Res; 2016 Sep; 145():46-50. PubMed ID: 27479532
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
Gando S; Saitoh D; Ishikura H; Ueyama M; Otomo Y; Oda S; Kushimoto S; Tanjoh K; Mayumi T; Ikeda T; Iba T; Eguchi Y; Okamoto K; Ogura H; Koseki K; Sakamoto Y; Takayama Y; Shirai K; Takasu O; Inoue Y; Mashiko K; Tsubota T; Endo S;
Crit Care; 2013 Dec; 17(6):R297. PubMed ID: 24342495
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis.
Wiedermann CJ; Kaneider NC
Blood Coagul Fibrinolysis; 2006 Oct; 17(7):521-6. PubMed ID: 16988545
[TBL] [Abstract][Full Text] [Related]
7. Risk stratification utilizing sequential organ failure assessment (SOFA) score, antithrombin activity, and demographic data in sepsis-associated disseminated intravascular coagulation (DIC).
Iba T; Maier CL; Tanigawa T; Levy JH
Sci Rep; 2023 Dec; 13(1):22502. PubMed ID: 38110515
[TBL] [Abstract][Full Text] [Related]
8. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
Iba T; Thachil J
Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin concentrate use in sepsis-associated disseminated intravascular coagulation: re-evaluation of a 'pendulum effect' drug using a nationwide database.
Tagami T
J Thromb Haemost; 2018 Mar; 16(3):458-461. PubMed ID: 29316251
[TBL] [Abstract][Full Text] [Related]
10. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
J Thromb Haemost; 2014 Sep; 12(9):1470-9. PubMed ID: 24943516
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of antithrombin III supplementation in an overt disseminated intravascular coagulation: a longitudinal single-institutional experience and retrospective analysis.
Lee S; Kim J; Ji M; Moon H; Lee W
Ann Palliat Med; 2024 May; 13(3):477-495. PubMed ID: 38735696
[TBL] [Abstract][Full Text] [Related]
12. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
[TBL] [Abstract][Full Text] [Related]
13. Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study.
Umemura Y; Yamakawa K; Hayakawa M; Kudo D; Fujimi S
Clin Appl Thromb Hemost; 2018 Jul; 24(5):734-740. PubMed ID: 29471674
[TBL] [Abstract][Full Text] [Related]
14. Antithrombin as Therapeutic Intervention against Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation: Lessons Learned from COVID-19-Associated Coagulopathy.
Wiedermann CJ
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293332
[TBL] [Abstract][Full Text] [Related]
15. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
[TBL] [Abstract][Full Text] [Related]
16. Impact of Antithrombin Supplementation and Concomitant Anticoagulation Therapy in Pediatric Patients With Disseminated Intravascular Coagulation.
Nagafuchi H; Eguchi Y; Ikeda T
Clin Appl Thromb Hemost; 2019; 25():1076029619834350. PubMed ID: 30836769
[TBL] [Abstract][Full Text] [Related]
17. New therapeutic options for patients with sepsis and disseminated intravascular coagulation.
Iba T; Yamada A; Hashiguchi N; Nagaoka I
Pol Arch Med Wewn; 2014; 124(6):321-8. PubMed ID: 24732306
[TBL] [Abstract][Full Text] [Related]
18. A Suggested Link Between Antithrombin Dose and Rate of Recovery from Disseminated Intravascular Coagulation in Patients with Severe Organ Failure.
Kuroda H; Tatsumi H; Sonoda T; Masuda Y
Clin Appl Thromb Hemost; 2022; 28():10760296221080942. PubMed ID: 35187966
[TBL] [Abstract][Full Text] [Related]
19. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.
Kienast J; Juers M; Wiedermann CJ; Hoffmann JN; Ostermann H; Strauss R; Keinecke HO; Warren BL; Opal SM;
J Thromb Haemost; 2006 Jan; 4(1):90-7. PubMed ID: 16409457
[TBL] [Abstract][Full Text] [Related]
20. Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation.
Kawano S; Uchino S; Endo A; Saito K; Iwai K; Kase Y; Takinami M
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):795-800. PubMed ID: 24806318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
